Bullfrog AI (NASDAQ:BFRG) Issues Earnings Results

Bullfrog AI (NASDAQ:BFRG) released its quarterly earnings results on Friday. The company reported ($0.11) EPS for the quarter, missing the consensus estimate of ($0.09) by ($0.02), FiscalAI reports. The firm had revenue of $0.06 million during the quarter, compared to analyst estimates of $0.21 million.

Bullfrog AI Price Performance

Shares of BFRG stock traded down $0.01 during trading on Friday, reaching $0.54. The company’s stock had a trading volume of 92,404 shares, compared to its average volume of 5,027,268. Bullfrog AI has a 1-year low of $0.43 and a 1-year high of $1.96. The stock’s 50-day moving average price is $0.55 and its 200 day moving average price is $0.64. The company has a market capitalization of $10.04 million, a price-to-earnings ratio of -1.18 and a beta of -2.60.

Insider Buying and Selling

In other Bullfrog AI news, CEO Vininder Singh bought 75,000 shares of Bullfrog AI stock in a transaction on Tuesday, September 22nd. The shares were bought at an average cost of $0.60 per share, for a total transaction of $45,000.00. Following the acquisition, the chief executive officer directly owned 2,442,446 shares in the company, valued at $1,465,467.60. This represents a 3.17% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CFO Joshua Blacher purchased 50,000 shares of the firm’s stock in a transaction on Tuesday, September 22nd. The stock was acquired at an average cost of $0.53 per share, with a total value of $26,500.00. Following the transaction, the chief financial officer directly owned 65,000 shares in the company, valued at $34,450. This trade represents a 333.33% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. 14.70% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

Separately, Weiss Ratings upgraded Bullfrog AI from a “sell (e+)” rating to a “sell (d-)” rating in a report on Friday, October 2nd. One investment analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, Bullfrog AI presently has a consensus rating of “Reduce”.

Bullfrog AI Company Profile

BullFrog AI Holdings, Inc. is a biotechnology-focused artificial intelligence company that develops machine-learning tools for the healthcare and life sciences industries. The company’s work is centered on using artificial intelligence to analyze complex biomedical data and support more efficient approaches to drug development and precision medicine. Its primary technology platform, bfLEAP, is designed to process and interpret large datasets, including genomic and clinical information. BullFrog AI offers data analysis and related services intended to help pharmaceutical companies, biotechnology firms, researchers and other healthcare organizations identify patterns, potential biomarkers, patient subgroups and other insights that may inform therapeutic development.